SEC Form 4Coverage since Jun 2, 2026
$CRBP insider trading
Over the last 12 months, Corbus Pharmaceuticals Holdings insiders reported 2 buys totaling $101K and 3 sales totaling $73K across SEC Form 4 filings. 60% of the activity was filed under pre-arranged 10b5-1 trading plans.
- Bought · 12m
- $101K 2 events
- Sold · 12m
- $73K 3 events
- Events · 12m
- 5 Form 4 filings, grouped
- Insiders · 12m
- 4 distinct reporters
- 10b5-1 share
- 60% pre-arranged plans
Side
Price · $CRBP · 12Mvia TradingView
Top insiders · 12m
Saxena Nishant CChief Business Officer2× · $101K
Kung Winston—1× · $16K
Altmeyer Anne—1× · $19K
Jenkins John Kenneth—1× · $38K
All insider trades
5 events
| Date | Insider | Type | Shares | Avg price | Value | Δ stake | Marks |
|---|---|---|---|---|---|---|---|
| Jun 10, 2026 | Kung WinstonD | ▼ Sale | 2,026 | $7.91 | $16K | -14.3% | plan |
| Jun 10, 2026 | Altmeyer AnneD | ▼ Sale | 2,412 | $7.91 | $19K | -24.1% | plan |
| Jun 10, 2026 | Jenkins John KennethD | ▼ Sale | 4,800 | $7.91 | $38K | -55.6% | plan |
| Jun 3, 2026 | Saxena Nishant CChief Business Officer · O | ▲ Buy | 9,000 | $7.58 | $68K | +13.6% | — |
| Jun 2, 2026 | Saxena Nishant CChief Business Officer · O | ▲ Buy | 4,500 | $7.33 | $33K | +7.3% | — |
About Form 4
Corporate insiders — officers, directors and 10%+ owners — must report their trades to the SEC on Form 4 within two business days. We group each filing's transactions into one economic event (a laddered 10b5-1 sale is one event, not 25 rows), flag pre-arranged plans and late filings, and link every event to its AI-scored article in the $CRBP feed.